Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Tsivia, Hochman"'
Autor:
Lawrence B. Gardner, Iman Osman, Judith D. Goldberg, Tsivia Hochman, Tomas Kirchhoff, Lisa Sikkema, Nathaniel Fleming, Ding Wang, Eleazar Vega-Saenz de Miera, Jordan Wengrod, Heidi L. Gold
PDF file - 151K, Supplemental Table 1. mutations found in NYU cohort and previously discovered by Hodis et al; and Krauthammer et al; Supplemental Table 2. Breslow-Day test of homogeneity for association between PP6C, BRAF, or NRAS mutations in Prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5703292c1022f392e566cc8fb21b5024
https://doi.org/10.1158/1541-7786.22510969
https://doi.org/10.1158/1541-7786.22510969
Autor:
Sandra Demaria, Derya Unutmaz, Nina Bhardwaj, Silvia C. Formenti, Judith D. Goldberg, Amy Tiersten, Yelena Novik, James Speyer, Deborah Axelrod, Nicholas Shuman, Tsivia Hochman, Leonard Liebes, Luis Chiriboga, Tze-Chiang Meng, Frank Martiniuk, Lina Kozhaya, Sylvia Adams
PDF file, 73K.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e941155b1c7e8d3cc24e61f8b1abf4c
https://doi.org/10.1158/1078-0432.22451633.v1
https://doi.org/10.1158/1078-0432.22451633.v1
Autor:
Sandra Demaria, Derya Unutmaz, Nina Bhardwaj, Silvia C. Formenti, Judith D. Goldberg, Amy Tiersten, Yelena Novik, James Speyer, Deborah Axelrod, Nicholas Shuman, Tsivia Hochman, Leonard Liebes, Luis Chiriboga, Tze-Chiang Meng, Frank Martiniuk, Lina Kozhaya, Sylvia Adams
XLS file, 17K, Patient demographics, tumor characteristics, treatment, occurrence and severity of local and systemic adverse events and anti-tumor response per patient (n=10).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c37747be5fba5d7a74ff9460f7bf397
https://doi.org/10.1158/1078-0432.22451630
https://doi.org/10.1158/1078-0432.22451630
Autor:
Sandra Demaria, Derya Unutmaz, Nina Bhardwaj, Silvia C. Formenti, Judith D. Goldberg, Amy Tiersten, Yelena Novik, James Speyer, Deborah Axelrod, Nicholas Shuman, Tsivia Hochman, Leonard Liebes, Luis Chiriboga, Tze-Chiang Meng, Frank Martiniuk, Lina Kozhaya, Sylvia Adams
PDF file, 282K, A (non-responder 1): In situ TILs analysis by IHC in a patient with minimal T cell infiltrate before treatment (H&E stain and IHC for CD3, CD4, CD8 and FoxP3, 200x). B: (non-responder 2): In situ TILs analysis by IHC in a patient with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99efac0f0070a2a325128efab3e5feff
https://doi.org/10.1158/1078-0432.22451636.v1
https://doi.org/10.1158/1078-0432.22451636.v1
Autor:
Michael J. Garabedian, Susan K. Logan, Fernando Augusto Soares, Luiz Fernando Lima Reiz, Robert J. Schneider, Judith D. Goldberg, Tsivia Hochman, Rezina Arju, Ellinor Oxelmark, S. Joseph Huang, Shah Giashuddin, Renecia Watkins, W. Marcus Lambert, Natalie E. Simpson
p23 is a heat shock protein 90 (Hsp90) cochaperone located in both the cytoplasm and nucleus that stabilizes unliganded steroid receptors, controls the catalytic activity of certain kinases, regulates protein-DNA dynamics, and is upregulated in sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02037b5e78f161ad699597e220100d75
https://doi.org/10.1158/0008-5472.c.6500681.v1
https://doi.org/10.1158/0008-5472.c.6500681.v1
Autor:
Michael J. Garabedian, Susan K. Logan, Fernando Augusto Soares, Luiz Fernando Lima Reiz, Robert J. Schneider, Judith D. Goldberg, Tsivia Hochman, Rezina Arju, Ellinor Oxelmark, S. Joseph Huang, Shah Giashuddin, Renecia Watkins, W. Marcus Lambert, Natalie E. Simpson
Supplementary Figures 1-8, Tables 1-7 from High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cbea6ec0080da138448a5d6a0c2ed6e
https://doi.org/10.1158/0008-5472.22383854
https://doi.org/10.1158/0008-5472.22383854
Autor:
Benjamin T. Cooper, Judith D. Goldberg, Jessica Chew, Moses Tam, Tsivia Hochman, Silvia C. Formenti, C.A. Perez, Nelly Huppert, Elecia Peat, O.G. Maisonet, F. Shaikh, Juhi M. Purswani, Naamit K. Gerber
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 101:1159-1167
Hypofractionated whole-breast radiation therapy (RT) has proved to be equivalent to conventionally fractionated RT in multiple randomized trials. There is controversy regarding its use in younger women because of their underrepresentation in trials a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68d36fb31b00b24d4e3c53638f3c2309
https://doi.org/10.1016/j.ijrobp.2018.04.034
https://doi.org/10.1016/j.ijrobp.2018.04.034
Autor:
Maher Abdul-Hay, Tsivia Hochman, Judith D. Goldberg, Benedetto Bruno, A. Samer Al-Homsi, Kelsey Stocker, Frank Cirrone, J Andres Suarez-Londono, Kelli Cole
Publikováno v:
Blood. 138:3892-3892
Introduction. Prevention of graft-versus-host disease (GvHD) following allogeneic hematopoietic cell transplantation (AHCT) remains a major challenge. The combination of methotrexate (MTX) and a calcineurin inhibitor has been the standard regimen for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::759c6789c245584641a20e2d33871ed8
https://doi.org/10.1182/blood-2021-151809
https://doi.org/10.1182/blood-2021-151809
Autor:
Tracy Butler, Craig S. Atwood, Lisa D. Ravdin, James E. Galvin, Lidia Glodzik, Mony J. de Leon, Richard L. Bowen, Thomas R. Maloney, Judith D. Goldberg, Tsivia Hochman
Publikováno v:
Contemp Clin Trials
The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer’s) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer’s disease (AD). Leuprolide acetat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64cca3746f06f07cc6c4a7f21cc5144a
https://doi.org/10.1016/j.cct.2021.106488
https://doi.org/10.1016/j.cct.2021.106488
Autor:
Judith D. Goldberg, Heather T. Gold, Elliot Newman, Tsivia Hochman, Daniel Lin, Benjamin Levinson, Lawrence Leichman, Maria R. Khan
Publikováno v:
Cancer Causes & Control. 29:253-260
Prior studies of timeliness of adjuvant chemotherapy (AC) initiation in stage III colon cancer have suggested longer time to AC at public compared with private hospitals. Few studies have explored differences in AC completion. We investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73050c673153a0d1eda3a7d86023f759
https://doi.org/10.1007/s10552-017-0996-6
https://doi.org/10.1007/s10552-017-0996-6